Award
National Cancer Institute 5U01CA286811-03
Assessing benefits and harms of cannabis use in patients treated with immunotherapy for cancer: a prospective cohort study
Recipient
State University of New York at Buffalo
Award Amount
$629,354.00
Ceiling
$629,354.00
Awarded
August 20, 2025
Identifier
5U01CA286811-03
A prospective cohort study to assess the benefits and harms of cannabis use in cancer patients undergoing immunotherapy, focusing on symptom management, immune function, and disease progression.
Description
This study aims to generate long-term data on the impact of cannabis use on benefits, harms, immune function, and disease progression in cancer patients treated with immune checkpoint inhibitors (ICIs). It involves a 12-month prospective cohort study with 450 cancer patients, assessing cannabis use, benefits, harms, and immunological markers.